Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 26 January 2018
Accepted: 26 January 2018
First Online: 16 February 2018
Conflict of interest
: B. Kiesewetter declares that she has no competing interests. M. Dediu declares consultancy and speaker fees from Roche, Astellas, Boehringer Ingelheim, Amgen, Novartis, TEVA, Sandoz, Merck, Pfizer, Astra-Zeneca, BMS, Eli Lilly, Johnson and Johnson. R. Bartsch declares lecture honoraria, advisory role, and travel support from Pfizer and advisory role for Eli-Lilly.